广济药业,000952,收入构成,报告日期,2021-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 制剂系列产品,4656,3621,1035,22.23%,8.5% 原料系列产品,25910,15691,10219,39.44%,83.95% 其他(补充),86,138,-52,-60.9%,-0.43% 其他,1679,708,971,57.82%,7.98% 广济药业,000952,收入构成,报告日期,2020-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 制剂系列产品,10903,6377,4526,41.51%,16.19% 原料系列产品,53992,32669,21323,39.49%,76.25% 其他(补充),126,72,54,42.59%,0.19% 其他,3796,1736,2060,54.28%,7.37% 广济药业,000952,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 制剂系列产品,2809,-- ,-- ,--,--% 原料系列产品,29225,-- ,-- ,--,--% 其他业务,94,-- ,-- ,--,--% 其他,1958,-- ,-- ,--,--% 广济药业,000952,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 原料系列产品,55448,29740,25708,46.36%,75.66% 其他,5098,3272,1826,35.82%,5.37% 其他(补充),1054,521,533,50.61%,1.57% 制剂系列产品,11534,5622,5913,51.26%,17.4% 广济药业,000952,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 制剂系列产品,4789,1904,2884,60.23%,15.28% 其他,2400,1331,1069,44.55%,5.66% 其他业务,83,66,17,20.92%,0.09% 原料系列产品,29277,14368,14909,50.92%,78.97% 广济药业,000952,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 制剂系列产品,8697,4979,3718,42.75%,7.75% 其他业务,703,527,177,25.12%,0.37% 原料系列产品,71410,28891,42519,59.54%,88.68% 其他,3574,2039,1535,42.94%,3.2% 广济药业,000952,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 制剂系列产品,3083,2177,905,29.37%,3.48% 其他(补充),22,1,21,97.35%,0.08% 原料系列产品,34827,10505,24322,69.84%,93.46% 其他,2141,1366,775,36.21%,2.98% 广济药业,000952,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),730,545,186,25.4%,0.45% 其他,3394,1853,1541,45.4%,3.78% 制剂系列产品,7114,3708,3407,47.89%,8.35% 原料系列产品,68917,33256,35661,51.74%,87.42% 广济药业,000952,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 原料系列产品,29936,15151,14785,49.39%,83.9% 制剂系列产品,3773,1958,1815,48.1%,10.3% 其他(补充),121,102,19,15.77%,0.11% 其他,2121,1118,1003,47.3%,5.69% 广济药业,000952,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),328,213,115,35.04%,0.31% 其他,3178,1920,1258,39.58%,3.37% 制剂系列产品,6946,3882,3064,44.11%,8.21% 原料系列产品,61020,28157,32864,53.86%,88.11% 广济药业,000952,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1859,1331,528,28.4%,3.54% 制剂系列产品,3577,2108,1469,41.06%,9.84% 原料系列产品,26256,13327,12929,49.24%,86.62% 广济药业,000952,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),352,177,176,49.86%,0.97% 其他,2633,1480,1153,43.8%,6.37% 制剂系列产品,3924,3056,868,22.12%,4.79% 原料系列产品,49126,33218,15908,32.38%,87.87% 广济药业,000952,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 制剂系列,1426,1015,411,28.81%,8.92% 其他(补充),-- ,-- ,-- ,--,0% 原料系列,15592,12068,3525,22.6%,76.48% 其他,1482,809,673,45.42%,14.6% 广济药业,000952,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),298,113,185,62%,4.07% 原料系列产品,41885,38715,3170,7.57%,69.94% 制剂系列产品,4223,3702,521,12.33%,11.49% 其他,2180,1522,657,30.16%,14.5% 广济药业,000952,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),184,122,62,33.68%,2.04% 其他,972,1114,-141,-14.55%,-4.66% 制剂系列产品,2392,2014,378,15.79%,12.43% 原料系列产品,19496,16757,2739,14.05%,90.18% 广济药业,000952,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),606,132,474,78.2%,7.91% 其他,3392,3098,294,8.66%,4.9% 制剂系列产品,4108,3937,171,4.15%,2.85% 原料系列产品,40603,35553,5050,12.44%,84.34% 广济药业,000952,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),415,1,414,99.87%,17.61% 其他,1713,1211,502,29.31%,21.33% 制剂系列产品,1981,1754,227,11.48%,9.67% 原料系列产品,18647,17438,1209,6.48%,51.39% 广济药业,000952,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),382,108,274,71.68%,20.15% 其他,2259,4114,-1855,-82.14%,-136.48% 制剂系列产品,3739,3263,475,12.71%,34.94% 原料系列产品,33036,30571,2466,7.46%,181.38% 广济药业,000952,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 输液,956,835,121,12.62%,6.69% 其他,690,682,8,1.12%,0.43% 原料系列产品,19180,17592,1588,8.28%,88.07% 其他(补充),-0,-- ,-- ,--,0% 水,115,114,0,0.23%,0.01% 片剂,594,508,86,14.55%,4.8% 牙膏系列产品,-- ,-- ,-- ,--,0% 广济药业,000952,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1890,1284,605,32.03%,6.45% 水,164,185,-21,-12.85%,-0.22% 牙膏系列产品,271,168,102,37.77%,1.09% 输液,2042,2081,-39,-1.9%,-0.41% 片剂,752,743,8,1.1%,0.09% 原料系列产品,40078,31413,8665,21.62%,92.29% 其他(补充),136,68,68,50.17%,0.73% 广济药业,000952,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),55,-- ,-- ,--,0% 其他,958,580,378,39.46%,6.55% 水,79,99,-20,-24.84%,-0.34% 牙膏系列产品,243,150,92,38.06%,1.6% 输液,1155,1096,58,5.06%,1.01% 片剂,405,417,-11,-2.81%,-0.2% 原料系列产品,22490,17221,5269,23.43%,91.37% 广济药业,000952,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2054,1477,576,28.06%,6.21% 水,139,160,-21,-15.33%,-0.23% 牙膏系列产品,430,253,177,41.11%,1.91% 输液,2762,2191,571,20.68%,6.16% 片剂,252,658,-407,-161.62%,-4.38% 原料系列产品,42464,34081,8383,19.74%,90.34% 广济药业,000952,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1249,819,430,34.45%,6.91% 水,68,82,-14,-20.19%,-0.22% 牙膏系列产品,218,127,91,41.9%,1.47% 输液,1252,1071,180,14.4%,2.89% 片剂,334,371,-38,-11.25%,-0.6% 原料系列产品,23508,17926,5582,23.74%,89.56% 广济药业,000952,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1779,1051,728,40.92%,7.76% 水,130,151,-21,-15.81%,-0.22% 牙膏系列产品,433,271,162,37.38%,1.72% 输液,3852,3355,497,12.91%,5.3% 片剂,595,690,-95,-15.97%,-1.01% 原料系列产品,37983,29867,8116,21.37%,86.46% 广济药业,000952,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 输液,2078,1861,218,10.48%,6.58% 原料系列产品,16387,13295,3092,18.87%,93.42% 广济药业,000952,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 VB2系列产品,49623,27749,21873,44.08%,94.85% 其他,2054,1734,320,15.57%,1.39% 水,135,152,-18,-13.04%,-0.08% 牙膏系列产品,440,268,172,39.09%,0.75% 输液,4305,3677,628,14.59%,2.72% 片剂,621,537,85,13.62%,0.37% 广济药业,000952,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 VB2系列产品,33156,16792,16363,49.35%,96.03% 其他,1205,642,563,46.74%,3.31% 水,65,74,-9,-13.71%,-0.05% 牙膏系列产品,210,121,88,42.11%,0.52% 输液,2098,2116,-18,-0.87%,-0.11% 片剂,426,374,52,12.26%,0.31% 广济药业,000952,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 VB2系列产品,72777,28705,44072,60.56%,96.44% 其他,1898,1168,730,38.46%,1.6% 水,118,160,-41,-34.95%,-0.09% 牙膏系列产品,254,137,116,45.89%,0.25% 输液,4027,3260,767,19.05%,1.68% 片剂,416,361,55,13.23%,0.12% 广济药业,000952,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 输液,2465,1927,538,21.83%,5.27% 核黄素,22970,13306,9665,42.07%,94.73% 广济药业,000952,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 VB2系列产品,31892,21662,10231,32.08%,87.31% 其他,1490,1460,30,2.04%,0.26% 输液,5087,3713,1374,27.01%,11.73% 替硝唑片剂,400,318,83,20.7%,0.71% 广济药业,000952,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 输液,4160,3600,560,13.46%,7.28% 核黄素,23252,16127,7125,30.64%,92.72% 广济药业,000952,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 VB2系列产品,15556,11038,4517,29.04%,85.64% 其他,670,558,112,16.68%,2.12% 输液,2854,2196,658,23.05%,12.47% 替硝唑片剂,25,38,-12,-48.21%,-0.23% 广济药业,000952,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 制剂产品,1287,941,345,26.85%,14.39% 核黄素,7306,5250,2056,28.14%,85.61% 广济药业,000952,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 VB2系列产品,28846,21605,7241,25.1%,85.23% 其他,1336,1335,2,0.14%,0.02% 输液,4236,3044,1192,28.13%,14.03% 替硝唑片剂,165,104,61,37.06%,0.72% 广济药业,000952,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 替硝唑,2849,2377,473,16.59%,9.52% 核黄素,20496,16005,4491,21.91%,90.48% 广济药业,000952,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,592,565,27,4.6%,0.83% 替硝唑片剂,63,49,14,22.03%,0.42% 替硝唑,2047,1513,534,26.09%,16.23% 核黄素,13353,10638,2715,20.34%,82.53% 广济药业,000952,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,280,184,97,34.46%,5.46% 输液,751,630,121,16.1%,6.84% 替硝唑片剂,31,24,7,21.27%,0.37% 核黄素,6205,4660,1545,24.89%,87.33% 广济药业,000952,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,514,0,514,100%,1.86% 输液,3038,0,3038,100%,10.98% 替硝唑片剂,324,0,324,100%,1.17% 核黄素,23787,0,23787,100%,85.99% 广济药业,000952,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,500,604,-105,-20.92%,-2.43% 输液,1552,1713,-161,-10.34%,-3.73% 替硝唑片剂,167,78,89,53.12%,2.06% 核黄素,16978,12499,4478,26.38%,104.1% 广济药业,000952,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 核黄素,11199,8169,3030,27.06%,100% 广济药业,000952,收入构成,报告日期,2004-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,226,223,3,1.32%,0.21% 输液,453,531,-78,-17.22%,-5.51% 替硝唑片剂,17,13,3,20.53%,0.25% 核黄素,5645,4157,1488,26.35%,105.05% 广济药业,000952,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,486,0,486,100%,2.38% 输液,1324,0,1324,100%,6.49% 替硝唑片剂,322,0,322,100%,1.58% 核黄素,18278,0,18278,100%,89.56% 广济药业,000952,收入构成,报告日期,2003-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,488,445,43,8.83%,0.78% 输液,789,568,221,28.04%,4% 替硝唑片剂,253,123,130,51.45%,2.36% 核黄素,12780,7650,5131,40.15%,92.86% 广济药业,000952,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,327,267,60,18.4%,1.5% 输液,532,360,172,32.37%,4.29% 替硝唑片剂,157,64,93,59.17%,2.32% 核黄素,8781,5088,3693,42.06%,91.9% 广济药业,000952,收入构成,报告日期,2003-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,133,119,14,10.58%,0.67% 输液,307,194,114,36.99%,5.4% 替硝唑片剂,75,29,46,61.13%,2.16% 核黄素,4851,2916,1935,39.89%,91.78% 广济药业,000952,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,440,366,74,16.82%,0.99% 输液,1534,1278,257,16.72%,3.43% 替硝唑片剂,417,152,265,63.55%,3.54% 核黄素,17824,10934,6890,38.66%,92.04% 广济药业,000952,收入构成,报告日期,2002-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 VB2系列产品,8823,5292,3531,40.02%,93.84% 其他,151,132,19,12.78%,0.51% 输液,844,764,80,9.49%,2.13% 替硝唑片剂,202,69,132,65.57%,3.51% 广济药业,000952,收入构成,报告日期,2001-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,146,0,146,100%,0.79% 替硝唑产品,2554,0,2554,100%,13.72% 核黄素产品,15907,0,15907,100%,85.49%